journal article Aug 20, 2010

Temsirolimus for metastatic desmoplastic small round cell tumor

Pediatric Blood & Cancer Vol. 55 No. 7 pp. 1431-1432 · Wiley
View at Publisher Save 10.1002/pbc.22755
Abstract
AbstractDesmoplastic small round cell tumor (DSRCT) is a rare and aggressive neoplasm that mostly occurs in young males. No curative treatment options currently exist for this type of tumor and long‐term survival remains poor. In vitro rapamycin induces apoptotic death of JN‐DSRCT‐1 cells, a possible model for desmoplastic small round cell tumors in which the EWS gene is fused to the WT1 gene. We therefore demonstrate the prolonged activity of temsirolimus, an mTOR‐inhibitor, in a patient with DSRCT. Pediatr Blood Cancer. 2010;55:1431–1432. © 2010 Wiley‐Liss, Inc.
Topics

No keywords indexed for this article. Browse by subject →

References
8
[2]
Chang F "Desmoplastic small round cell tumors: Cytologic, histologic, and immunohistochemical features" Arch Pathol Lab Med (2006) 10.5858/2006-130-728-dsrctc
Cited By
38
Pediatric Blood & Cancer
Metrics
38
Citations
8
References
Details
Published
Aug 20, 2010
Vol/Issue
55(7)
Pages
1431-1432
License
View
Cite This Article
Anna M.J. Thijs, Winette T.A. van der Graaf, Carla M.L. van Herpen (2010). Temsirolimus for metastatic desmoplastic small round cell tumor. Pediatric Blood & Cancer, 55(7), 1431-1432. https://doi.org/10.1002/pbc.22755